2022 Corporate Members














Adaptive Biotechnologies, Blueprint Medicines, Boehringer Ingelheim, Taiho Oncology
Aveo Oncology, Gilead, Karyopharm Therapeutics

Commercial support by these organizations does not influence the objectives of Northern New England Clinical Oncology Society